The gap.
The peptide research category is messy on the public web. Most of what a curious reader finds is either a wall of supplier copy that reads like a brochure, a forum thread written by an anonymous user, or a clinical paper behind a paywall written for specialists. None of those formats is right for someone trying to learn the field from a standing start.
We built Apothify in the gap. The library presents every peptide as a structured entry, written for a general reader, with the same five sections in the same order: what it is, how it works, what researchers explore it for, safety and interactions, and research notes. Every entry uses the same vocabulary. Every entry is reviewed by the same editorial team against the same banned phrase list. Every entry is built to compare cleanly against every other entry in the library.
The discipline.
The single most important commitment behind Apothify is compliance discipline. Peptide research sits in a regulated space; the line between "this is a research compound studied in cell models for X" and language that would imply a therapeutic claim is a line that matters, and one we never cross.
The build pipeline that ships this site enforces that line mechanically. A banned phrase scan runs against every page, every email, every product field, every guide; the build fails on any forbidden phrase, regardless of who wrote the copy. The phrase "researchers have explored…" is the canonical framing for every entry. Products are sold for laboratory research use only and are not for human consumption. That sentence appears in some form on every commerce surface on the site.
That discipline is not a brand decision; it is a structural one. Anyone working on this site, including the people who write the editorial copy and the engineers who add features, operates inside that constraint by default. That is how we keep the library defensible at scale.
Understanding first.
Apothify is organized in that order on purpose: encyclopedia first, discovery tool second, commerce third. Every peptide has a research entry that exists whether or not a product version is for sale. Many of the 124 compounds in the library are encyclopedia coverage only, listed for educational completeness, with no commerce pathway, because of regulatory status or internal compliance review. We list them anyway because a researcher trying to understand the field needs to see the whole field, not just the subset that happens to be purchasable.
The Compare tool was built to support the same posture. A side by side comparison of two peptides surfaces the facts a reader actually needs to evaluate either compound: research area, complexity, what researchers commonly pair the compound with, and known interactions. It never recommends a use, a dose, a route, or a combination.
The team.
Apothify is operated by Apothify LLC, a Wyoming limited liability company. The editorial team writes and reviews every peptide page, every guide, and every category intro. The engineering team builds the catalog, the discovery tools, and the commerce backend on a static first stack on Cloudflare Pages with full edge caching and HSTS preload. That is the technical posture of a serious publishing operation rather than a typical ecommerce storefront.
If you are a journalist, a researcher, a partner, or a curious reader who wants to talk to a real person at Apothify, the help center reaches the team directly, and the media page has press contact information.
Start here.
If you are new to the field, start with the learning library. If you have an area in mind, the peptide finder surfaces the most cited compounds in that area in four short questions. If you have two compounds in mind already, the comparison tool lines them up point by point. If you need definitions, the terminology page covers the vocabulary used across the site in plain language. And if you just want to browse, the full library is right there with every entry in the catalog.
Welcome to Apothify.
